Home Contact Center Add this

Debiopharm Group™

A bridge between the discovery of new molecules and patient access

Debiopharm Group is a Swiss-based global biopharmaceutical group of four companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investment management. The group in-licenses and develops promising drug candidates. The products are commercialized by pharmaceutical out-licensing partners to give access to the largest number of patients worldwide.

Besides drug development, Debiopharm has recently developed in-house skills in the field of companion diagnostics with a view to benefit from the key opportunities in personalized medicine.

Debiopharm Group independently funds the worldwide development of all of its products while providing expertise in all areas.

Societies

The Auditing Committee

monitors and enhances good administrative and management practices as well as risk control at group level.

More info

The Strategic Committee

is a prospective think-tank advising the shareholders and the leadership of the group against the background of a changing environment. 


More info

Rolland-Yves Mauvernay

Rolland-Yves Mauvernay

Co-President & Founder, Debiopharm Group™

Dr Mauvernay completed his medical studies at the Faculty of Medicine and Pharmacy at the University of Strasbourg, France and later obtained his Ph.D. in Biology, Bacteriology and Pharmacy. In 1953, he established RIOM Laboratories, in Auvergne, France and purchased several pharmaceutical laboratories and various rare molecules. In 1973, he sold RIOM and in 1979, founded Debiopharm International SA, a biopharmaceutical development company which fully funds and develops innovative therapeutics. He later created Debiopharm Research & Manufacturing SA, specializing in the development of sustained-release advanced drug delivery systems and manufacturing. Today, Dr Mauvernay heads a group of 350 employees, supported by 500 external experts, who are responsible for research and development.

Thierry Mauvernay

Thierry Mauvernay

Co-President & Delegate of the Board, Debiopharm Group™

Mr Mauvernay received his Master of Science in Economics in 1975. He then obtained a degree (MBA) from the 'Institut d'Administration des Entreprises’ and a DESS in Marketing (Master II Degree) in Clermont-Ferrand, France in 1976. In 1978, he founded an international cosmetics company, which he sold in 1998 but continued to manage until July 2001, when he joined Debiopharm International SA as Executive Vice President with direct responsibilities for the Finance and Administration Department. In 2006, Mr Mauvernay handed over his operational activities within Debiopharm International SA and has since been focusing on the administration, finance and strategy of Debiopharm Group. Since 2012, Mr Mauvernay is the Delegate of the Board of Debiopharm Group.

Debiopharm Group™

Forum "après-demain"
Chemin Messidor 5-7
Case postale 5911
CH-1002 Lausanne
Switzerland

Tel. +41 (0)21 321 0111
Fax. +41 (0)21 321 0169